Cannabis Law Report
FEBRUARY 10, 2022
Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. In response to the DEA’s letter, AIMS, Dr. Aggarwal, and two patients seeking access to psilocybin under the RTT Act filed a lawsuit in the U.S. 2007), the D.C. Enter the Right to Try (RTT) Act.
Cannabis Law Report
OCTOBER 29, 2019
Some of the conditions thought to be relieved by hemp consumption were: pain, inflammation, anxiety and phobia, digestive system issue, and pruritus ( 39 ). 2007) 68:258–64. 2007) 174:54–61. J Soc Sci. (2007) 2:106–16. Luna SP, Basílio AC, Steagall PV, Machado LP, Moutinho FQ, Takahira RK, et al. Am J Vet Res.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 11, 2019
Despite the recent legalization of cannabis, a framework for access to cannabis for medical purposes still exists, but under new regulations passed under the authority of the Cannabis Act. Robichaud , 2007 NBQB 50. Prior to that, cannabis was regulated under the Controlled Drugs and Substances Act. Footnotes. 4 Poirier v.
SpeedWeed
MARCH 14, 2021
Carl Ruck, “Since the wine of Dionysus is a mediation between the god’s wild herbal ancestors and the civilized phenomenon of his cultivated and manufactured manifestation in the product fermented from the juice of the grape, it is most probable that this was the way in which the Greeks incorporated hemp into their pharmacopoeia” (Ruck, 2007).
Expert insights. Personalized for you.
52 
Let's personalize your content